1. Introduction {#sec1-molecules-21-01125}
===============

Plants of the genus *Buxus* are abundant in triterpenoid alkaloids (*Buxus* alkaloids), comprised of more than 140 analogues with a 9,10-cyclopropyl ring system and a degraded C-20 side chain \[[@B1-molecules-21-01125]\]. Some of these alkaloids have been demonstrated to have antimalarial, antituberculosis, anti-HIV, and anticancer activities \[[@B2-molecules-21-01125],[@B3-molecules-21-01125],[@B4-molecules-21-01125],[@B5-molecules-21-01125],[@B6-molecules-21-01125],[@B7-molecules-21-01125],[@B8-molecules-21-01125],[@B9-molecules-21-01125]\]. One of these plants, *B. microphylla* Sieb. et Zucc. (Buxaceae), native to Southern China, is an evergreen shrub and usually planted to beautify the environment \[[@B10-molecules-21-01125]\]. Moreover, twigs and leaves of this plant are used in folkloric medicine for the treatment of tumor, stomachache, hernia, and acute myocardial ischemia \[[@B10-molecules-21-01125]\]. In our continuous search for active alkaloids from this plant \[[@B11-molecules-21-01125],[@B12-molecules-21-01125],[@B13-molecules-21-01125]\], three new triterpenoid alkaloids, namely buxmicrophyllines P--R (**1**--**3**), were isolated from the twigs and leaves of *B. microphylla*. The three compounds (shown in [Figure 1](#molecules-21-01125-f001){ref-type="fig"}) were evaluated for their cytotoxic activities in five human tumor cell lines. Herein, we described the isolation, structure elucidation, and cytotoxicity of these compounds.

2. Results and Discussion {#sec2-molecules-21-01125}
=========================

Three new triterpenoid alkaloids (**1**--**3**) were obtained by chromatographic separation of the acetone extract of the twigs and leaves of *B. microphylla*.

Compound **1**, an amorphous powder, gave a molecular formula C~28~H~48~N~2~O on the basis of High Resolution Electrospray Ionization Mass Spectroscopy (HR-ESI-MS) spectrum (*m*/*z* 445.3795 \[M + H\]^+^, calculated for C~28~H~49~N~2~O, 445.3797). The ^1^H- and ^13^C-DEPT NMR spectra ([Table 1](#molecules-21-01125-t001){ref-type="table"} and [Supplementary Materials Figures S1--S6](#app1-molecules-21-01125){ref-type="app"}) of **1** displayed signals for seven methyls (three tertiary singlets at δ~H~ 0.96, 0.98, and 1.12), nine methylenes (two typical cyclopropyl protons at δ~H~ 0.59 (d, *J* = 4.0 Hz) and 0.33 (d, *J* = 4.0 Hz)), seven methines, and five quaternary carbons. These functionalities suggested that **1** is a typical 9β,10β-cycloartane type triterpenoid alkaloid \[[@B12-molecules-21-01125]\]. Further analysis of the NMR data revealed that the structure of **1** was parallel to that of cyclobuxoxazine \[[@B12-molecules-21-01125],[@B14-molecules-21-01125]\], except for the presence of an additional secondary methyl group (δ~C~ 21.7 and δ~H~ 1.30 (d, *J* = 5.5 Hz)) and a methine group (δ~C~ 85.3 and δ~H~ 4.29) replacing the methylene group (δ~C~ 79.5) at C-1′ in the latter, suggesting that the methyl group should be located at C-1′. This deduction could be further confirmed by the ^1^H-Detected Heteronuclear Multiple Bond Correlation (HMBC) of H-1′ to C-3 and C-30 and the ^1^H-^1^H Correlation Spectroscopy (^1^H-^1^H COSY) of H-2′/H-1′ ([Figure 2](#molecules-21-01125-f002){ref-type="fig"}). The H-1′ proton was assigned as α-oriented by the Rotating-frame Overhauser Enhancement Spectroscopy (ROESY) from H-1′ to Hα-30 ([Figure 2](#molecules-21-01125-f002){ref-type="fig"}). Thereby, the structure of **1** was defined as shown and named buxmicrophylline P.

Compound **2** yielded the molecular formula C~37~H~56~N~2~O~6~ based on its ^13^C-NMR and the HR-ESI-MS ion peak at *m*/*z* 625.4216 \[M + H\]^+^ (calculated 625.4212), 180 mass units more than that of **1**, suggesting that it is a syringoylated derivative of **1**. The additional syringoyl group (δ~H~ 7.27 (s, 2H); δ~C~ 165.8, 121.8, 106.5, 146.7, 139.1) and the downfiled shift of C-16 (from δ~C~ 78.9 to δ~C~ 80.4) allowed the location of the syringoyl group at C-16, as confirmed by the HMBC correlations of H-16 (δ~H~ 5.26) to the carbonyl carbon (δ~C~ 165.8) of the syringoyl group, C-20, and C-14 ([Figure 3](#molecules-21-01125-f003){ref-type="fig"}). The β-orientation of H-16 was assigned as that of **1** by ROESY correlations of H-16/H-18 ([Figure 3](#molecules-21-01125-f003){ref-type="fig"}). The structure of **2** (buxmicrophylline Q) was therefore depicted as shown.

Similarly, the structure of compound **3** (buxmicrophylline R), which has the molecular formula C~36~H~54~N~2~O~5~ as determined by the HR-ESI-MS ion peak at 595.4111 \[M + H\]^+^ (calculated 595.4106), was established by comparing its NMR data with those of **1** and **2**. It turned out that there was a vanilloyl group (δ~H~ 7.60, 7.57, 6.91; δ~C~ 165.8, 123.4, 111.8, 149.5, 146.1, 113.8, 123.7) in **3** rather than a syringoyl group. The location of the vanilloyl group was also at C-16, as confirmed from the HMBC cross peaks of H-16 with the carbonyl carbon (δ~C~ 165.8, [Figure 4](#molecules-21-01125-f004){ref-type="fig"}).

Compounds **1**--**3** were tested for their cytotoxic effects against five human tumor cell lines ([Table 2](#molecules-21-01125-t002){ref-type="table"}). Compared with the positive control cisplatin, compound **3** displayed the most potent cytotoxicity against MCF-7 cells with IC~50~ values of 4.51 μM. However, the other tested compounds did not exert any cytotoxic effect, even at 40 μM.

3. Experimental Section {#sec3-molecules-21-01125}
=======================

3.1. General Information {#sec3dot1-molecules-21-01125}
------------------------

Optical rotations were measured with a JASCO P-1020 polarimeter (JASCO Corporation, Tokyo, Japan). UV spectra were obtained using a Shimadzu UV 2401PC instrument (Shimadzu, Tokyo, Japan). Infrared spectra were recorded on a Bruker Tensor-27 instrument (Bruker, Zurich, Switzerland) by using KBr pellets. 1D and 2D-NMR experiments were performed on Bruker AV-400 and DRX-500 instruments (Bruker) with TMS as internal standard. HR-ESI-MS data were acquired on an API QSTAR Pulsar spectrometer (Applied Biosystems, Carlsbad, CA, USA). Column chromatography (CC) was performed on SiO~2~ (200--300 mesh, Qingdao Marine Chemical Group Corporation, Qingdao, China).

3.2. Plant Material {#sec3dot2-molecules-21-01125}
-------------------

The twigs and leaves of *B. microphylla* were collected from Kunming, Yunnan Province, China, in September 2013, and identified by Zong-Yu Wang (Kunming Institute of Botany, Yunnan, China). A voucher specimen (KIB. Bm-20130915) has been deposited at the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences.

3.3. Extraction and Isolation {#sec3dot3-molecules-21-01125}
-----------------------------

The chopped, dried plant material of *B. microphylla* (10.0 kg) was extracted three times with acetone (20 L) at room temperature, seven days each time. The filtrate was concentrated under reduced pressure to yield a residue (500 g), which was further suspended in 0.001 N HCl and partitioned with ethyl acetate (EtOAc). The aqueous layer was alkalinized to pH 10.0 with 2 N NaOH followed by exhaustive extraction with CHCl~3~. The CHCl~3~-soluble fraction (120 g) was chromatographed on a silica gel column, eluted with CHCl~3~--MeOH (100:0, 50:1, 20:1, 10:1, 2:1) to give five fractions, A1--A5. Fraction A4 (12 g) was subjected to further silica gel column chromatography using petroleum ether--EtOAc--diethylamine (20:1:1, 10:1:1, 5:1:1, 2:1:1), to yield **1** (20 mg), **2** (4 mg), **3** (5 mg).

*Buxmicrophylline P* (**1**): White amorphous powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ +6.8 (*c* = 0.18, MeOH); UV (MeOH) λ~max~ (log ε) 240 (2.13) nm; IR (KBr) ν~max~ 3426, 2938, 2870, 2719, 1634, 1460cm^−1^; ^1^H and ^13^C-NMR data, see [Table 1](#molecules-21-01125-t001){ref-type="table"}; HRESIMS *m*/*z* 445.3795 (calcd. for C~28~H~49~N~2~O, 445.3797).

*Buxmicrophylline Q* (**2**): White amorphous powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ −1.8 (*c* = 0.29, MeOH); UV (MeOH) λ~max~ (log ε) 270 (2.49) nm; IR (KBr) ν~max~ 3429, 2936, 2866, 1708, 1460cm^−1^; ^1^H and ^13^C-NMR data, see [Table 1](#molecules-21-01125-t001){ref-type="table"}; HRESIMS *m*/*z* 625.4216 (calcd. for C~37~H~57~N~2~O~6~, 625.4212).

*Buxmicrophylline R* (**3**): White amorphous powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ −13.7 (*c* = 0.15, MeOH); UV (MeOH) λ~max~ (log ε) 240 (2.56), 265 (2.44) nm; IR (KBr) ν~max~ 3430, 2936, 1710, 1632, 1461, 1292 cm^−1^; ^1^H and ^13^C-NMR data, see [Table 1](#molecules-21-01125-t001){ref-type="table"}; HRESIMS *m*/*z* 595.4111 (calcd. for C~36~H~55~N~2~O~5~, 595.4106).

3.4. Cytotoxicity Assay {#sec3dot4-molecules-21-01125}
-----------------------

Compounds **1**--**3** were tested in vitro for their cytotoxicities against five human tumor cell lines (promyelocytic leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung adenocarcinoma A-549, breast cancer MCF-7, and colon adenocarcinoma SW480) by the microculture tetrazolium (MTT) assay. Cytotoxicity evaluations were performed based on the previously described protocol \[[@B12-molecules-21-01125]\], with cisplatin as the positive control. Briefly, after 24 h incubation in 96-well plates, each tumor cell line was exposed to **1**--**3** or positive control at final concentrations of 1, 2, 5, 10, 20, and 40 μM for 72 h. At the end of exposure, 20 μL of 5 mg/mL MTT (Sigma-Aldrich, St. Louis, MO, USA) was added to each well, and the plates were incubated for another 4 h. Then, 100 μL 20% SDS was added, and the plates were further incubated for 12 h. The optical density (OD) was read on a plate reader at 570 nm. IC~50~ values were expressed as concentration of a compound reducing cell growth by 50%. All samples were assayed in triplicate.

4. Conclusions {#sec4-molecules-21-01125}
==============

Phytochemical investigations of *B. microphylla* afforded three new 9,19-cycloartane type alkaloids, buxmicrophyllines P--R (**1**--**3**), together with a known analogue, buxbodine B. In vitro cytotoxicity assay proved that compound **3** exhibited more potent cytotoxic activity against MCF-7 cell line than the positive control, making this compound a potential lead entity for further study.
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###### 

^1^H-NMR and ^13^C-NMR data of compounds **1**--**3** ^a^.

  ----------------------------------------------------------------------------------------------------------
  No.           1             2                3                                            
  ------------- ------------- ---------------- ------------- ---------------- ------------- ----------------
  1             33.0, CH~2~   1.26 m; 1.63 m   32.9, CH~2~   1.28 m; 1.61 m   33.0, CH~2~   1.29 m; 1.65 m

  2             27.4, CH~2~   1.43 m; 1.53 m   27.1, CH~2~   1.42 m; 1.55 m   27.4, CH~2~   1.46 m; 1.57 m

  3             63.3, CH      2.60 m           63.2, CH      2.60 m           63.3, CH      2.60 m

  4             37.1, C       \-               37.0, C       \-               37.1, C       \-

  5             45.0, CH      1.35 m           44.8, CH      1.35 m           44.8, CH      1.35 m

  6             19.9, CH~2~   0.79 m; 1.29 m   19.7, CH~2~   1.84 m; 1.25 m   19.8, CH~2~   0.81 m; 1.26 m

  7             25.3, CH~2~   1.11 m; 1.29 m   25.1, CH~2~   1.02 m; 1.25 m   25.2, CH~2~   1.05 m; 1.25 m

  8             47.3, CH      1.51 m           46.7, CH      1.60 m           46.8, CH      1.57 m

  9             19.1, C       \-               18.9, C       \-               19.0, C       \-

  10            25.3, C       \-               25.7, C       \-               25.8, C       \-

  11            25.9, CH~2~   1.10 m; 2.00 m   26.0, CH~2~   1.11 m; 1.99 m   26.1, CH~2~   1.10 m; 2.01 m

  12            31.5, CH~2~   1.45 m; 1.61 m   32.1, CH~2~   1.58 m; 1.72 m   32.3, CH~2~   1.59 m; 1.74 m

  13            44.8, C       \-               44.7, C       \-               44.9, C       \-

  14            47.3, C       \-               47.7, C       \-               47.8, C       \-

  15            44.4, CH~2~   1.34 m; 1.85 m   44.5, CH~2~   1.41 m; 1.95 m   44.5, CH~2~   1.42 m; 1.98 m

  16            78.9, CH      4.05 m           80.4, CH      5.26 m           80.3, CH      5.30 m

  17            56.9, CH      1.84 m           56.4, CH      2.27 m           56.6, CH      2.29 m

  18            18.7, CH~3~   0.96 s           18.8, CH~3~   1.00 s           18.9, CH~3~   1.03 s

  19            30.7, CH~2~   0.59 d (4.0)\    30.2, CH~2~   0.60 brs\        30.4, CH~2~   0.63 d (4.0)\
                              0.33 d (4.0)                   0.33 d brs                     0.36 d (4.0)

  20            62.4, CH      2.63 m           59.7, CH      2.55 m           59.8, CH      2.57 m

  21            9.6, CH~3~    0.87 d (6.4)     9.4, CH~3~    0.84 d (5.8)     9.6, CH~3~    0.86 d (6.4)

  30            77.3, CH~2~   3.74 d (10.7)\   77.2, CH~2~   3.73 d (10.9)\   77.3, CH~2~   3.75 d (10.7)\
                              3.31 d (10.7)                  3.28 d (10.9)                  3.31 d (10.7)

  31            11.4, CH~3~   0.98 s           11.3, CH~3~   0.97 s           11.6, CH~3~   0.99 s

  32            20.9, CH~3~   1.12 s           19.5, CH~3~   1.11 s           19.5, CH~3~   1.14 s

  1'            85.3, CH      4.29 m           85.1, CH      4.28 m           85.3, CH      4.28 m

  2'            21.7, CH~3~   1.30 d (5.5)     21.5, CH~3~   1.28 d (5.4)     21.7, CH~3~   1.31 d (5.4)

  N(CH~3~)~2~   40.1, CH~3~   2.09 s           40.4, CH~3~   2.10 s           40.3, CH~3~   2.10 s

  OCH~3~        \-            \-               56.2, CH~3~   3.88 s           56.0, CH~3~   3.93 s

  OSyr ^b^\     \-            \-               165.8, C\     7.27 s           165.8, C\     7.60 brdd\
  (OVan) ^b^                                   121. 8, C\                     123.4, C\     7.57 brd\
                                               106.5, CH\                     111.8, CH\    6.91 d (8.3)
                                               146.7, C\                      149.5, C\     
                                               139.1, C                       146.1, C\     
                                                                              113.8, CH\    
                                                                              123.7, CH     
  ----------------------------------------------------------------------------------------------------------

^a^ δ in ppm, *J* in Hz, 600 MHz for ^1^H and 150 MHz for ^13^C, in CDCl~3~. ^b^ OSyr stands for syringoyl group; OVan stands for vanilloyl group.
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###### 

Cytotoxic activities of compounds **1**--**3** with IC~50~ values (μM).

  Compounds   Cell Lines                           
  ----------- ------------ ------- ------- ------- -------
  **1**       \>40         \>40    \>40    \>40    \>40
  **2**       \>40         \>40    \>40    \>40    \>40
  **3**       13.88        15.58   11.76   4.51    13.71
  Cisplatin   1.22         4.48    6.18    15.23   11.99
